The clinical trials of Oxford vaccine will continue in India as usual as it has faced no issue at all, the Serum Institute of India (SII) said on Wednesday over the recent report of phase-three study of the COVID-19 vaccine being put on hold in the United Kingdom, as one of the participants reported a suspected severe adverse reaction